Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other financing activities: 2022-2023

Historic Other financing activities for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Dec 2023 value amounting to $363,000.

  • Madrigal Pharmaceuticals' Other financing activities was N/A to $75,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $363,000 for FY2023, which is 59.03% down from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Other financing activities of $363,000 as of FY2023, which was down 59.03% from $886,000 recorded in FY2022.
  • In the past 5 years, Madrigal Pharmaceuticals' Other financing activities ranged from a high of $886,000 in FY2022 and a low of $363,000 during FY2023.
  • For the 2-year period, Madrigal Pharmaceuticals' Other financing activities averaged around $624,500, with its median value being $624,500 (2022).
  • Data for Madrigal Pharmaceuticals' Other financing activities shows a maximum YoY tumbled of 59.03% (in 2023) over the last 5 years.
  • Madrigal Pharmaceuticals' Other financing activities (Yearly) stood at $886,000 in 2022, then crashed by 59.03% to $363,000 in 2023.